患者报告的恶心后实施一个增强后手术恢复协议后,为妇科瘤患者
Kristina Lindemann1,2, Svana Heimisdottir Danbolt3, Lene Ramberg4
1Department of Gynecological Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway klinde@ous-hf.no.
手术后改善恢复 (ERAS) 协议改善了在妇科瘤患者的手术后恶心和吐 (PONV) 预防的坚持. 然而,患者报告的恶心仍然存在,这表明ERAS计划中的未满足的临床需求.
科学领域:
- 妇科瘤学 妇科瘤学
- 手术患者护理手术患者护理
- 麻醉学 麻醉学
背景情况:
- 手术后增强恢复 (ERAS) 协议旨在优化患者的康复.
- 手术后恶心和吐 (PONV) 是一个常见的并发症,特别是在妇科瘤手术中.
- 坚持PONV预防策略对于患者的治疗结果至关重要.
研究的目的:
- 评估在妇科瘤患者实施ERAS协议后对PONV预防策略的遵守情况.
- 分析患者在ERAS协议实施前后报告的恶心.
- 评估ERAS对PONV预防和患者结局的影响.
主要方法:
- 一项前性观察性研究,比较了ERAS前和ERAS后的队列.
- 包括为盆腔质量或卵巢癌进行腹腔切除术的患者.
- 将分层分为手术程度队列和前性数据收集.
主要成果:
- 在ERAS后队列中增加了双重PONV预防 (84%对64%).
- 在需要救援药物或患者在第二天报告的恶心方面没有显著差异.
- 较低的外科手术周流体给药与更少的恶心有关,但在多变量分析中不显著.
结论:
- 通过实施ERAS协议,加强了对PONV预防指南的遵守.
- 患者报告的恶心仍然是ERAS中的妇科瘤患者的一个重要问题.
- 患者报告的结果措施对于评估ERAS有效性至关重要.
更多相关视频
07:14A Quantitative Sensory Testing Paradigm to Obtain Measures of Pain Processing in Patients Undergoing Breast Cancer Surgery
Published on: January 18, 2018
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Assessment of the Gastrointestinal System II: Health Perception Pattern
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
